TRZSX
Price
$15.65
Change
-$0.06 (-0.38%)
Updated
Sep 12 closing price
Net Assets
23.71B
VTMNX
Price
$19.25
Change
-$0.07 (-0.36%)
Updated
Sep 12 closing price
Net Assets
242.06B
Interact to see
Advertisement

TRZSX vs VTMNX

Header iconTRZSX vs VTMNX Comparison
Open Charts TRZSX vs VTMNXBanner chart's image
T. Rowe Price Overseas Stock Z
Price$15.65
Change-$0.06 (-0.38%)
VolumeN/A
Net Assets23.71B
Vanguard Developed Markets Index Instl
Price$19.25
Change-$0.07 (-0.36%)
VolumeN/A
Net Assets242.06B
TRZSX vs VTMNX Comparison Chart in %
Loading...
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTMNX has more cash in the bank: 242B vs. TRZSX (23.7B). TRZSX pays higher dividends than VTMNX: TRZSX (2.78) vs VTMNX (2.63). TRZSX was incepted earlier than VTMNX: TRZSX (6 years) vs VTMNX (25 years). TRZSX (0.65) is less costly to investors than VTMNX (0.03). TRZSX is a more actively managed with annual turnover of: 8.70 vs. VTMNX (3.00). TRZSX has a lower initial minimum investment than VTMNX: TRZSX (0) vs VTMNX (5000000). TRZSX annual gain was more profitable for investors over the last year : 18.29 vs. VTMNX (16.91). TRZSX return over 5 years is better than : 64.35 vs. VTMNX (47.25).
TRZSXVTMNXTRZSX / VTMNX
Total Expense Ratio0.000.03-
Annual Report Gross Expense Ratio0.650.032,167%
Fund Existence6 years25 years-
Gain YTD24.60225.48197%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets23.7B242B10%
Annual Yield % from dividends2.782.63106%
Returns for 1 year18.2916.91108%
Returns for 3 years62.7351.57122%
Returns for 5 years64.3547.25136%
Returns for 10 yearsN/A71.22-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MSGE44.270.97
+2.24%
Madison Square Garden Entertainment Corp
ASPC10.330.03
+0.29%
A Spac III Acquisition Corp
OWL18.75N/A
N/A
Blue Owl Capital
DDI9.27-0.04
-0.43%
DoubleDown Interactive Co Ltd
TRIB1.19-0.01
-0.83%
Trinity Biotech plc